… tratamiento de la espasticidad infantil resulta más económico … is not the same in both products
27 , toxins are not comparable. … Therefore, its results correspond to real clinical practice in …

… The results demonstrated that the participants were treated with BTX-A … of botulinum toxin
type A efficacy on spasticity and functional outcome in children with spastic cerebral palsy. …

… either the fetal or the infant brain, affecting the development … A recent study [27] used
quantitative sensory testing (QST) to … after botulinum toxin injections in children with cerebral palsy …

… in the developing fetal or infant brain” [Citation1]. CP is the most … CP [Citation27] and recently
by the Cerebral Palsy Research … We do not report any adverse side effects of BoNTA in this …

… No side effects were recorded. When compared to the … Participant 27 presented with left hip
dislocation and also … motor skills at 2 years of age that are normally found in an infant of up to …

… for about 60%–70% of cases. Injury to the cone system of the … long time, most up to 6 months
[27]. After a single injection of … Short-term effects of botulinum toxin A and serial casting on …

… 90% have spastic forms (unilateral or bilateral) that result in abnormal … infant”; “adolescent”)
and “spasticity”. We deliberately chose not to use the term “cerebral palsy” because spasticity …

… Botulinum toxin is considered as an effective treatment for … Our results showed that judicious
use of botulinum injections … The median age of the patients was 51 months with range of 27 …

… In all cases, botulinum toxin A was added to the oral baclofen … in the treatment of spastic
equinus foot in cerebral palsy. The … years of age, and a maximum dose of 60 mg/day if >8 years …

… can be made for botulinum toxin-A and radial extracorporeal … Spasticity is the result of chronic
loss of inhibitory … known short-term adverse events, 27 but research in our target population …